ArticleScientific reports2026
The development and validation of a clinical measurement tool for fear of recurrence and progression in cardiac patients.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One in two cardiac patients fear having another heart event or their cardiac condition worsening. Assessment of fear of recurrence and progression (FoRP) is critical to effective clinical care and chronic disease management. The current study aimed to develop and validate a measure of cardiac-FoRP - The Fear of Cardiac Recurrence and Progression Inventory (FCRPI). Items were generated by reviewing relevant literature and were refined in collaboration with key informants. The item pool (44 items) was administered to 241 adults (mean age = 64.52; 50% female) with a history of an acute coronary event, cardiac surgery, or chronic cardiac condition. Exploratory factor analysis identified the underlying factor structure and Rasch analysis assessed fit and reduced the item set. The final FCRPI comprised 29 items across five fear subscales relating to: deteriorating health, requiring further treatment, disengagement and loss of agency, impacts on intimacy, and impacts on work and finance, and two fear response subscales: avoidance and hyperawareness. The FCRPI demonstrated excellent internal consistency, and criterion and discriminant validity, and a clinically significant cut-off score of 39 was identified. The FCRPI offers both research and clinical utility by providing a validated tool to assess cardiac-specific FoRP and guide tailored interventions and patient-centred care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.